Skip to main content
NovartisFacility expansion

Novartis: towards a reduction of 130 positions in Basel

What happened

Novartis plans to transform its Rhine campus into a center for biological treatments by moving laboratories there by the end of 2028.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

The laboratories responsible for providing support to biological cell banks, analytical testing, and technical development activities are to be moved by the end of 2028 from the Petit-Bâle district to the Novartis campus. The latter plans to transform its Rhine campus into a center for biological treatments, the group specified in a press release. This new restructuring of Novartis' activities in Switzerland comes nine months after the announcement of the last wave of job cuts, Unia notes in a statement. The union emphasizes that the multinational has thus eliminated nearly 3000 jobs in Switzerland since 2018 and is concerned about a questioning of production in the country by the group's management. The employee defense organization also calls for political awareness, considering that a company benefiting from advantageous tax conditions and the quality of Swiss infrastructure should in return be required to invest in research, development, and production in Switzerland. (sda/awp/ats)

watson.ch/fr/suisse/emploi/740858060-novartis-vers-une-reduction-de-1...Read the full source

Extracted by Autobound

From the Signal API record
Event
Facility expansion

What this signalsA bigger facility often needs new equipment, systems and services.

Takes effect
Dec 31, 2028
Location
Basel, Basel-Stadt, Switzerland

More facility expansion signals at other companies

The full record

From the Signal API record

Extraction

Confidence
90%
Detected
Sep 2, 2026
signal_type
news
signal_subtype
expands_facilities

Use this data

Get every facility expansion signal for Novartis and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Novartis this week?”

  2. Send it to your own tools

    The Signal API returns facility expansion signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b6a99e2d-e282-31aa-3b51-0bc8ef915e5f returns this record as JSON. POST /v1/companies/enrich returns every signal for novartis.com.

{
  "signal_id": "b6a99e2d-e282-31aa-3b51-0bc8ef915e5f",
  "signal_type": "news",
  "signal_subtype": "expands_facilities",
  "detected_at": "2026-09-02T15:52:46+00:00",
  "company": {
    "name": "Novartis",
    "domain": "novartis.com"
  },
  "data": {
    "url": "https://www.watson.ch/fr/suisse/emploi/740858060-novartis-vers-une-reduction-de-130-postes-a-bale",
    "title": "Novartis: towards a reduction of 130 positions in Basel - Watson",
    "excerpt": "The laboratories responsible for providing support to biological cell banks, analytical testing, and technical development activities are to be moved by the end of 2028 from the Petit-Bâle district to the Novartis campus. The latter plans to transform its Rhine campus into a center for biological treatments, the group specified in a press release. This new restructuring of Novartis' activities in Switzerland comes nine months after the announcement of the last wave of job cuts, Unia notes in a statement. The union emphasizes that the multinational has thus eliminated nearly 3000 jobs in Switzerland since 2018 and is concerned about a questioning of production in the country by the group's management. The employee defense organization also calls for political awareness, considering that a company benefiting from advantageous tax conditions and the quality of Swiss infrastructure should in return be required to invest in research, development, and production in Switzerland. (sda/awp/ats)",
    "summary": "Novartis plans to transform its Rhine campus into a center for biological treatments by moving laboratories there by the end of 2028.",
    "location": "Basel, Switzerland",
    "planning": true,
    "image_url": "https://www.watson.ch/fr/imgdb/e007/Z1200,675,833,468,333,188/968843238769982",
    "confidence": 0.9,
    "published_at": "2026-09-02T15:52:46Z",
    "location_data": [
      {
        "city": "Basel",
        "state": "Basel-Stadt",
        "region": "Western Europe",
        "country": "Switzerland",
        "continent": "Europe",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2028-12-31",
    "article_sentence": "The latter plans to transform its Rhine campus into a center for biological treatments, the group specified in a press release."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.